# Jack Henry & Associates Inc: financial statements, quarterly

JKHY · Nasdaq · CIK 779152 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/jkhy.md) · [Financials](/companies/jkhy/financials.md) · [Filings](/companies/jkhy/filings.md) · [Insiders](/companies/jkhy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jkhy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [571](/filings/0000779152-24-000111.md) | [546](/filings/0000779152-25-000009.md) | [539](/filings/0000779152-25-000019.md) | [560 d](/filings/0000779152-26-000067.md) | [601](/filings/0000779152-25-000092.md) | [574](/filings/0000779152-26-000009.md) | [585](/filings/0000779152-26-000025.md) | [615 d](/filings/0000779152-26-000067.md) | [645](/filings/0000779152-25-000092.md) | [619](/filings/0000779152-26-000009.md) | [636](/filings/0000779152-26-000025.md) | [644 d](/filings/0000779152-26-000067.md) |
| Cost of revenue | $m | [323](/filings/0000779152-24-000111.md) | [321](/filings/0000779152-25-000009.md) | [328](/filings/0000779152-25-000019.md) | [327 d](/filings/0000779152-26-000067.md) | [343](/filings/0000779152-25-000092.md) | [333](/filings/0000779152-26-000009.md) | [341](/filings/0000779152-26-000025.md) | [344 d](/filings/0000779152-26-000067.md) | [349](/filings/0000779152-25-000092.md) | [351](/filings/0000779152-26-000009.md) | [364](/filings/0000779152-26-000025.md) | [370 d](/filings/0000779152-26-000067.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [36.9](/filings/0000779152-24-000111.md) | [35.5](/filings/0000779152-25-000009.md) | [36.0](/filings/0000779152-25-000019.md) | [39.9 d](/filings/0000779152-26-000067.md) | [39.7](/filings/0000779152-25-000092.md) | [41.1](/filings/0000779152-26-000009.md) | [39.4](/filings/0000779152-26-000025.md) | [42.6 d](/filings/0000779152-26-000067.md) | [39.3](/filings/0000779152-25-000092.md) | [42.2](/filings/0000779152-26-000009.md) | [45.1](/filings/0000779152-26-000025.md) | [49.8 d](/filings/0000779152-26-000067.md) |
| Selling, general and administrative | $m | [78.8](/filings/0000779152-24-000111.md) | [70.3](/filings/0000779152-25-000009.md) | [62.2](/filings/0000779152-25-000019.md) | [67.1 d](/filings/0000779152-26-000067.md) | [66.6](/filings/0000779152-25-000092.md) | [76.9](/filings/0000779152-26-000009.md) | [66.4](/filings/0000779152-26-000025.md) | [73.2 d](/filings/0000779152-26-000067.md) | [72.8](/filings/0000779152-25-000092.md) | [67.0](/filings/0000779152-26-000009.md) | [72.2](/filings/0000779152-26-000025.md) | [87.2 d](/filings/0000779152-26-000067.md) |
| Operating income | $m | [133](/filings/0000779152-24-000111.md) | [119](/filings/0000779152-25-000009.md) | [112](/filings/0000779152-25-000019.md) | [126 d](/filings/0000779152-26-000067.md) | [151](/filings/0000779152-25-000092.md) | [123](/filings/0000779152-26-000009.md) | [139](/filings/0000779152-26-000025.md) | [156 d](/filings/0000779152-26-000067.md) | [184](/filings/0000779152-25-000092.md) | [159](/filings/0000779152-26-000009.md) | [155](/filings/0000779152-26-000025.md) | [137 d](/filings/0000779152-26-000067.md) |
| Interest expense | $m | [4.2](/filings/0000779152-23-000099.md) | [3.9](/filings/0000779152-24-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [31.6](/filings/0000779152-24-000111.md) | [28.3](/filings/0000779152-25-000009.md) | [27.1](/filings/0000779152-25-000019.md) | [29.3 d](/filings/0000779152-26-000067.md) | [37.6](/filings/0000779152-25-000092.md) | [29.5](/filings/0000779152-26-000009.md) | [30.8](/filings/0000779152-26-000025.md) | [32.3 d](/filings/0000779152-26-000067.md) | [46.3](/filings/0000779152-25-000092.md) | [39.5](/filings/0000779152-26-000009.md) | [35.6](/filings/0000779152-26-000025.md) | [28.5 d](/filings/0000779152-26-000067.md) |
| Net income | $m | [102](/filings/0000779152-24-000111.md) | [92.0](/filings/0000779152-25-000009.md) | [87.1](/filings/0000779152-25-000019.md) | [101 d](/filings/0000779152-26-000067.md) | [119](/filings/0000779152-25-000092.md) | [97.8](/filings/0000779152-26-000009.md) | [111](/filings/0000779152-26-000025.md) | [128 d](/filings/0000779152-26-000067.md) | [144](/filings/0000779152-25-000092.md) | [125](/filings/0000779152-26-000009.md) | [123](/filings/0000779152-26-000025.md) | [111 d](/filings/0000779152-26-000067.md) |
| Diluted EPS | $ per share | [1.39](/filings/0000779152-24-000111.md) | [1.26](/filings/0000779152-25-000009.md) | [1.19](/filings/0000779152-25-000019.md) | not reported | [1.63](/filings/0000779152-25-000092.md) | [1.34](/filings/0000779152-26-000009.md) | [1.52](/filings/0000779152-26-000025.md) | not reported | [1.97](/filings/0000779152-25-000092.md) | [1.72](/filings/0000779152-26-000009.md) | [1.71](/filings/0000779152-26-000025.md) | not reported |
| Basic EPS | $ per share | [1.40](/filings/0000779152-24-000111.md) | [1.26](/filings/0000779152-25-000009.md) | [1.20](/filings/0000779152-25-000019.md) | not reported | [1.63](/filings/0000779152-25-000092.md) | [1.34](/filings/0000779152-26-000009.md) | [1.53](/filings/0000779152-26-000025.md) | not reported | [1.98](/filings/0000779152-25-000092.md) | [1.73](/filings/0000779152-26-000009.md) | [1.71](/filings/0000779152-26-000025.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.5](/filings/0000779152-23-000099.md) | [26.7](/filings/0000779152-24-000018.md) | [27.3](/filings/0000779152-24-000033.md) | [38.3](/filings/0000779152-25-000019.md) | [43.2](/filings/0000779152-24-000111.md) | [25.7](/filings/0000779152-25-000009.md) | [39.9](/filings/0000779152-25-000019.md) | [102](/filings/0000779152-26-000025.md) | [36.2](/filings/0000779152-25-000092.md) | [28.2](/filings/0000779152-26-000009.md) | [20.6](/filings/0000779152-26-000025.md) | not reported |
| Current assets | $m | [563](/filings/0000779152-23-000099.md) | [554](/filings/0000779152-24-000018.md) | [523](/filings/0000779152-24-000033.md) | [632](/filings/0000779152-25-000055.md) | [635](/filings/0000779152-24-000111.md) | [580](/filings/0000779152-25-000009.md) | [593](/filings/0000779152-25-000019.md) | [681](/filings/0000779152-26-000067.md) | [652](/filings/0000779152-25-000092.md) | [616](/filings/0000779152-26-000009.md) | [595](/filings/0000779152-26-000025.md) | [649](/filings/0000779152-26-000067.md) |
| Total assets | $m | [2,734](/filings/0000779152-23-000099.md) | [2,754](/filings/0000779152-24-000018.md) | [2,770](/filings/0000779152-24-000033.md) | [2,924](/filings/0000779152-25-000055.md) | [2,929](/filings/0000779152-24-000111.md) | [2,912](/filings/0000779152-25-000009.md) | [2,932](/filings/0000779152-25-000019.md) | [3,044](/filings/0000779152-26-000067.md) | [3,048](/filings/0000779152-25-000092.md) | [3,060](/filings/0000779152-26-000009.md) | [3,051](/filings/0000779152-26-000025.md) | [3,146](/filings/0000779152-26-000067.md) |
| Current liabilities | $m | [471](/filings/0000779152-23-000099.md) | [404](/filings/0000779152-24-000018.md) | [375](/filings/0000779152-24-000033.md) | [634](/filings/0000779152-25-000055.md) | [571](/filings/0000779152-24-000111.md) | [497](/filings/0000779152-25-000009.md) | [436](/filings/0000779152-25-000019.md) | [536](/filings/0000779152-26-000067.md) | [436](/filings/0000779152-25-000092.md) | [385](/filings/0000779152-26-000009.md) | [341](/filings/0000779152-26-000025.md) | [556](/filings/0000779152-26-000067.md) |
| Total liabilities | $m | [1,074](/filings/0000779152-23-000099.md) | [1,030](/filings/0000779152-24-000018.md) | [991](/filings/0000779152-24-000033.md) | [1,082](/filings/0000779152-25-000055.md) | [1,003](/filings/0000779152-24-000111.md) | [936](/filings/0000779152-25-000009.md) | [896](/filings/0000779152-25-000019.md) | [913](/filings/0000779152-26-000067.md) | [874](/filings/0000779152-25-000092.md) | [857](/filings/0000779152-26-000009.md) | [916](/filings/0000779152-26-000025.md) | [1,094](/filings/0000779152-26-000067.md) |
| Long-term debt | $m | not reported | not reported | not reported | [60.0](/filings/0000779152-25-000055.md) | [50.0](/filings/0000779152-24-000111.md) | [60.0](/filings/0000779152-25-000009.md) | [80.0](/filings/0000779152-25-000019.md) | [0.0](/filings/0000779152-26-000025.md) | [20.0](/filings/0000779152-25-000092.md) | [20.0](/filings/0000779152-26-000009.md) | [90.0](/filings/0000779152-26-000025.md) | [40.0](/filings/0000779152-26-000067.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [90.0](/filings/0000779152-25-000055.md) | [90.0](/filings/0000779152-24-000111.md) | [90.0](/filings/0000779152-25-000009.md) | [90.0](/filings/0000779152-25-000019.md) | [0.0](/filings/0000779152-25-000055.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,660](/filings/0000779152-24-000111.md) | [1,724](/filings/0000779152-25-000009.md) | [1,780](/filings/0000779152-25-000019.md) | [1,842](/filings/0000779152-26-000067.md) | [1,925](/filings/0000779152-25-000092.md) | [1,976](/filings/0000779152-26-000009.md) | [2,036](/filings/0000779152-26-000025.md) | [2,131](/filings/0000779152-26-000067.md) | [2,173](/filings/0000779152-25-000092.md) | [2,203](/filings/0000779152-26-000009.md) | [2,135](/filings/0000779152-26-000025.md) | [2,052](/filings/0000779152-26-000067.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [157](/filings/0000779152-24-000111.md) | [81.5 d](/filings/0000779152-25-000009.md) | [97.6 d](/filings/0000779152-25-000019.md) | [232 d](/filings/0000779152-26-000067.md) | [117](/filings/0000779152-25-000092.md) | [89.6 d](/filings/0000779152-26-000009.md) | [108 d](/filings/0000779152-26-000025.md) | [327 d](/filings/0000779152-26-000067.md) | [121](/filings/0000779152-25-000092.md) | [153 d](/filings/0000779152-26-000009.md) | [186 d](/filings/0000779152-26-000025.md) | [303 d](/filings/0000779152-26-000067.md) |
| Capital expenditure | $m | [7.6](/filings/0000779152-24-000111.md) | [16.8 d](/filings/0000779152-25-000009.md) | [9.9 d](/filings/0000779152-25-000019.md) | [23.8 d](/filings/0000779152-26-000067.md) | [12.8](/filings/0000779152-25-000092.md) | [16.7 d](/filings/0000779152-26-000009.md) | [11.7 d](/filings/0000779152-26-000025.md) | [12.2 d](/filings/0000779152-26-000067.md) | [8.9](/filings/0000779152-25-000092.md) | [21.2 d](/filings/0000779152-26-000009.md) | [16.5 d](/filings/0000779152-26-000025.md) | [20.5 d](/filings/0000779152-26-000067.md) |
| Dividends paid | $m | [37.9](/filings/0000779152-24-000111.md) | [37.9 d](/filings/0000779152-25-000009.md) | [40.1 d](/filings/0000779152-25-000019.md) | [40.1 d](/filings/0000779152-26-000067.md) | [40.1](/filings/0000779152-25-000092.md) | [40.1 d](/filings/0000779152-26-000009.md) | [42.3 d](/filings/0000779152-26-000025.md) | [42.2 d](/filings/0000779152-26-000067.md) | [42.1](/filings/0000779152-25-000092.md) | [41.8 d](/filings/0000779152-26-000009.md) | [43.5 d](/filings/0000779152-26-000025.md) | [42.9 d](/filings/0000779152-26-000067.md) |
| Share repurchases | $m | [20.0](/filings/0000779152-24-000111.md) | [0.0 d](/filings/0000779152-25-000009.md) | [0.0 d](/filings/0000779152-25-000019.md) | [8.1 d](/filings/0000779152-26-000067.md) | [0.0](/filings/0000779152-25-000092.md) | [17.1 d](/filings/0000779152-26-000009.md) | [18.0 d](/filings/0000779152-26-000025.md) | [(0.0) d](/filings/0000779152-26-000067.md) | [62.0](/filings/0000779152-25-000092.md) | [63.2 d](/filings/0000779152-26-000009.md) | [159 d](/filings/0000779152-26-000025.md) | [164 d](/filings/0000779152-26-000067.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [73.1](/filings/0000779152-23-000099.md) | [73.1](/filings/0000779152-24-000018.md) | [73.1](/filings/0000779152-24-000033.md) | [73.0](/filings/0000779152-24-000111.md) | [73.0](/filings/0000779152-25-000009.md) | [73.0](/filings/0000779152-25-000019.md) | [73.1](/filings/0000779152-25-000092.md) | [73.1](/filings/0000779152-26-000009.md) | [73.0](/filings/0000779152-26-000025.md) | [72.9](/filings/0000779152-25-000092.md) | [72.4](/filings/0000779152-26-000009.md) | [72.0](/filings/0000779152-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 70,112,608 at 2026-08-12, from the cover of the [10-K filed 2026-08-28](/filings/0000779152-26-000067.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.